VLTO · NYSE · CIK 0001967680
Veralto Corporation
No equity stake in another company appears in Veralto Corporation's filings. That is the sourced answer, not a hole in the research.
Veralto Corporation - Profile
- Sector
- IndustrialsGICS
- Industry
- Instruments For Meas & Testing of Electricity & Elec SignalsSIC 3825
- Listed on
- NYSE
- Employees
- 17,000stated 2025
- Incorporated in
- United States
- Financial year ends
- 31 December
Source
Address, industry classification, listing and incorporation come from Veralto Corporation's own SEC filer record, so the industry is the SEC's dry classification rather than a marketing label. The website was checked for this site against the company's own pages. The headcount is the figure the sources below state for 2025. The description was written for this site in August 2026 from Veralto Corporation Form 10-K for the year ended December 31, 2025, Veralto (Wikipedia) and Veralto corporate site, not taken from any single article.
Share price
VLTO
Description
Veralto Corporation sells instruments, consumables, software and services for water quality testing and treatment and for marking, coding and packaging of consumer goods. It was created by the spin off of Danaher Corporation's Environmental and Applied Solutions segment on 30 September 2023, when Danaher distributed one Veralto share for every three Danaher shares held. The Water Quality segment, $3.32 billion of 2025 sales, covers Hach analytical instruments, ChemTreat treatment chemicals and Trojan Technologies ultraviolet and membrane systems sold to municipal utilities and industrial users. The Product Quality and Innovation segment, $2.18 billion, supplies Videojet and Linx marking and coding printers and Esko, X-Rite and Pantone packaging design and color tools. Total 2025 sales were $5.50 billion, up 6.0% on 2024, with recurring sales about 61% of the total and 56% of sales made outside the United States. Veralto is based in Waltham, Massachusetts and had nearly 17,000 employees at the end of 2025.
Who owns Veralto Corporation.
sized by
modelled, reported or pending
Select a row or a slice for its provenance: the filing it came from, when it was measured, and the arithmetic behind it if it was modelled.
The full register, from 13F filings
The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 1,017 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.
1,017 managers reported a position, together holding 230.4m shares, or 94.5% of the company. The 40 largest are listed. Percentages are of a share count taken later than this quarter, because the count in force at the snapshot is not published as a structured fact for this company. Where the count has moved since, the figures are off by that much.
Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.
What a reader needs to know to read these numbers
- SEPARATION DATE AND FORMER-PARENT STAKE, CONFIRMED BOTH WAYS. Veralto Corporation was incorporated in 2023 in connection with its separation from Danaher Corporation ("Danaher" or "Former Parent"), effective 30 Sep 2023, when Veralto Corporation consisted of Danaher's former Environmental & Applied Solutions segment. Per Veralto's own FY2025 10-K (Basis of Presentation, and the business description): 'The Separation was effectuated through a pro-rata dividend distribution on September 30, 2023 of all of the issued and outstanding shares of Veralto common stock held by Danaher as of September 13, 2023. Each Danaher stockholder of record as of the close of business on September 13, 2023 received one share of Veralto common stock...' The phrase 'all of the issued and outstanding shares...held by Danaher' is explicit that Danaher retained no Veralto shares itself; its own stockholders received the shares directly. Consistent with this, no Danaher-held Veralto stake appears anywhere in the register data checked (13F filings, the 2026 proxy's 5-percent-holder table, or Schedule 13G/13D filings under Veralto's own CIK), and Veralto's stockholders' equity rollforward shows the Former Parent's net investment account ("Net Former Parent Investment") reduced to zero at the Separation with no residual retained equity line for Danaher. This was not independently re-verified from Danaher's own filings within the time budget (Danaher was not researched as part of this task), so the parent-side confirmation rests on Veralto's own disclosure and the absence of any Danaher position in Veralto's ownership records, not on a cross-check of a dupont.json-style companion file the way the Qnity analogue used.
- FILING HISTORY UNDER THIS CIK (0001967680), from the EDGAR submissions feed. Registration: Form 10-12B filed 3 Aug 2023, amended twice (10-12B/A on 25 Aug and 31 Aug 2023) as Separation terms were finalized. Periodic reports: three 10-Ks (FY2023 filed 28 Feb 2024, FY2024 filed 25 Feb 2025, FY2025 filed 20 Feb 2026, the last of these used throughout this file for the equity-method/investments disclosure); the first 10-Q covering the stub period after Separation (filed 26 Oct 2023) plus quarterly 10-Qs through Q2 2026 (period 3 Jul 2026, filed 29 Jul 2026, the one used for the cover-page share count and confirmed to carry no material change to the equity-investments note versus the FY2025 10-K). Three DEF 14A proxies exist (2024, 2025, and the 2026 proxy filed 27 Mar 2026, used for the entire register side of this file's insider rows and as a cross-check for the stale institutional 13G figures). Multiple Schedule 13G/13G-A filings exist from The Vanguard Group, BlackRock, and T. Rowe Price Investment Management between 2023 and 2024; none more recent than Nov 2024 were found in the recent-filings window, which is why this file relies on fresh Q2 2026 13F data instead for the institutional register rows rather than a stale 13G. No 13D, no NT 10-K, no NT 10-Q appears in the history.
- HOLDINGS SIDE IS EMPTY, AS A SOURCED FINDING. Veralto's FY2025 10-K (Note on Investments, in the summary of significant accounting policies) discloses only a generic accounting policy for equity-method and non-marketable equity investments plus one immaterial, unnamed data point: 'The Company made minority investments in equity method investments and non-marketable equity securities totaling $7 million and $15 million in 2025 and 2024, respectively,' included within other long-term assets with no disclosed cumulative balance and no named investee. The filing separately mentions the Company is 'a limited partner in a partnership that invests in start-up companies,' again with no name, no ownership percentage, and no disclosed carrying value. Searched via filing.py search/prose across the FY2025 10-K for 'equity method', 'unconsolidated' (0 hits), 'joint venture' (7 hits, all in risk-factor boilerplate about acquisitions/investments/joint ventures generally, none naming a specific venture), 'investments in', 'non-marketable equity' (1 hit, the sentence above), and 'noncontrolling interest' (12 hits, all describing minority interests THIRD PARTIES hold in Veralto's OWN consolidated subsidiaries, i.e. the reverse direction from what this brief asks about; the balance is $1 million at 31 Dec 2025 and $7 million at 31 Dec 2024, with a $9 million 'Purchase of noncontrolling interests' in 2025 reducing it, meaning Veralto bought OUT a minority partner rather than acquiring a minority stake in someone else). The Q2 2026 10-Q was also searched and contains no equity-method, non-marketable, or joint-venture language at all (0 hits for each), confirming no new material position arose in H1 2026. No named investee exists in either filing to record as a holdings row; an empty holdings array is the correct sourced finding here, following the pattern the brief flags for most S&P 500-style companies (Broadcom cited as the example).
- SHARE BASIS. 243,793,344 shares of common stock outstanding at 21 Jul 2026 (Q2 2026 10-Q cover page), used for company.shares_outstanding and for every institutional 13F register row's pct_of_company. A separate, close but different count of 245,565,117 shares outstanding as of 23 Mar 2026 (2026 DEF 14A record date) is used only for the two insider rows' pct_of_company, left on the proxy's own as-filed basis rather than restated, consistent with the difference reflecting routine share repurchases between March and July 2026 (the equity rollforward in the 10-Q shows a 1.5 million share repurchase in the period) rather than any stock split; no split or reverse split has occurred since the 2023 Separation.
- PROXY 5-PERCENT TABLE IS STALE; FRESH 13F DATA WAS PREFERRED THROUGHOUT. The 2026 DEF 14A's own beneficial-ownership table sources its three named 5-percent-plus holders (Vanguard 29,199,453 sh / 11.8%, BlackRock 23,645,501 sh / 9.6%, T. Rowe Price Investment Management 10,627,157 sh / 4.3%) from Schedule 13G/A filings as of 30 Sep 2024, nearly two years stale relative to today. Per the chunk-prompt rule to prefer the fresh Q2 13F over any stale 13G quoted in a proxy, this file's institutional register rows instead use each holder's own Q2 2026 (30 Jun 2026) 13F-HR filing, refreshing Vanguard's family total UP to 30,753,481 shares (12.61%, from a fuller eight-entity sweep versus the proxy's single Vanguard Group entity), BlackRock DOWN to 22,647,953 shares (9.29%), and T. Rowe Price Investment Management UP to 13,712,810 shares (5.62%, now a genuine 5-plus percent holder, above the proxy's stale 4.3%). The stale proxy figures are kept here only as a reconciliation reference, not as the register's own basis.
- T. ROWE PRICE IS TWO SEPARATE REGISTRANTS, BOTH CHECKED, BOTH CARRYING THE THOUSANDS TRAP. T. Rowe Price Associates, Inc. (CIK 0000080255) and T. Rowe Price Investment Management, Inc. (CIK 0001897612) are legally distinct 13F filers; both were checked per the project checklist and both hold Veralto shares (642,689 and 13,712,810 respectively). Both filings' raw XML value fields were in thousands of dollars (implying an absurd $0.089 per share before rescaling by 1000 to match the roughly $88.7 per share cluster seen across every other Q2 2026 filer for CUSIP 92338C103); this has now been seen on multiple companies in this project and was checked for and corrected here.
- VANGUARD FAMILY SWEPT ACROSS ALL EIGHT ENTITIES KNOWN TO HOLD THIS CUSIP. The project's own pre-existing 13F-derived register file (data/registers/VLTO.json, period 31-Mar-2026, Vanguard family total 30,016,386 shares) already enumerated eight Vanguard-affiliated CIKs holding Veralto; all eight were individually re-checked against fresh Q2 2026 filings rather than assumed unchanged or limited to the two largest successors. This recovered the full 30,753,481-share family total (12.61% of the company) rather than an understated two-entity sum, per lesson 1 of the chunk prompt. Other Vanguard-affiliated 13F filers beyond these eight, if any exist, were not checked; see unknowns.
- INSIDER SIDE. Veralto has no founder or controlling shareholder; it is a 2023 spin-off with a single class of common stock. The clearest voting-power story is Chair and CEO Jennifer L. Honeycutt (450,477 shares per the 2026 proxy, the largest individual holding in the beneficial-ownership table) and the 18-person officers-and-directors group (1,049,518 shares combined). Honeycutt's row rolls up into the group row, which is marked is_aggregate with the residual (599,041 shares, the other 17 individually-named persons in the excerpted table plus any 18th person not captured in the specific text window read) described in residual_label, following the overlap-marking rule so the register chart does not double-count her position inside the group total.
- Register self-gate, computed the way the chart computes it (a member row counts at full value; the container it rolls into is reduced to its residual; every other row counts at full value): 9 register rows (7 institutional 13F rows on the 243,793,344-share basis, 1 named insider and 1 insider aggregate group on the 245,565,117-share proxy basis). Institutional subtotal: Vanguard family 30,753,481 + BlackRock 22,647,953 + T. Rowe Price Investment Management 13,712,810 + State Street 11,131,069 + Geode 7,389,874 + FMR 2,516,643 + T. Rowe Price Associates 642,689 = 88,794,519 shares (36.42% of 243,793,344). Insider side: Honeycutt 450,477 (full value) plus the group's residual 599,041 (1,049,518 minus Honeycutt's 450,477) = 1,049,518 shares total, computed on the proxy's own 245,565,117-share basis. Summed nominally across both bases for a single approximate total (the two share-count bases differ by only about 0.7 percent, so this mixing is a reasonable approximation, not a precise chart computation): 88,794,519 + 1,049,518 = 89,844,037 shares against the company's 243,793,344 shares outstanding = 36.85 percent. This sits comfortably within the expected 25 to 45 percent band.
- Market capitalization ($23.42 billion) is computed as shares_outstanding (243,793,344, from the 10-Q cover page) times the closing share price ($96.07, stockanalysis.com, 18 Aug 2026 4:00pm EDT close), giving $23,421,226,558, matching stockanalysis.com's own independently reported $23.42 billion figure. Note this closing price ($96.07) is well below the roughly $88.7 to $88.8 per share cluster implied by the Q2 2026 (30 Jun 2026 quarter-end) 13F filings used throughout the register; both prices are real and dated to their own snapshot, not a data error: the stock traded meaningfully higher in mid-2026 than it does as of the 18 Aug 2026 pricing date used here.
Looked for, not found
Recorded rather than filled in. Each of these is a place where a number could have been invented and was not.
- Individual names or carrying values of the two Veralto equity-method/non-marketable-equity investments referenced only as an aggregate ($7 million made in 2025, $15 million made in 2024, both amounts of NEW investment activity in the year, not a cumulative balance) and the unnamed 'partnership that invests in start-up companies' in which Veralto is a limited partner. Searched: FY2025 10-K and Q2 2026 10-Q via filing.py search/prose for 'equity method', 'unconsolidated', 'joint venture', 'non-marketable equity', 'noncontrolling interest', 'nonconsolidated', 'investments in'. No named investee or cumulative balance was found in either filing.
- Whether Danaher Corporation's own SEC filings (10-K, 10-Q, 13F, or 2026 proxy) independently confirm a zero retained Veralto stake. Danaher was not separately researched as part of this task; the Danaher-retained-nothing conclusion here rests entirely on Veralto's own 10-K disclosure and the absence of any Danaher position across Veralto's register-side sources (13F filings, the 2026 proxy's 5-percent table, Schedule 13G/13D filings), not on an independent Danaher-side filing read.
- Whether any Vanguard-affiliated 13F filer beyond the eight CIKs already identified in the project's pre-existing VLTO register file holds Veralto shares. All eight known entities were checked and summed; a filer outside that known set was not searched for independently.
- Whether any single named holder outside this file's nine rows (for example Wellington Management, Capital Group, Norges Bank, or Dodge & Cox, all flagged as recurring risk cases in the chunk prompt) holds a material Veralto position; not checked within the time budget.
- Whether Veralto's single class of common stock carries exactly one vote per share; searched the FY2025 10-K for 'one vote per share', 'entitled to one vote' and 'par value $0.01' with no exact-phrase match found within the time budget, so votes_per_share is left null.
- Full itemization of the 18-person officers-and-directors group in the 2026 proxy: the specific prose window read named 17 individuals (Honeycutt, Filler, Colpron, Comas, Kambeyanda, King, Lohr, Mitts, Sankaran, Schwieters, Wallis-Lage, Williams, Kapity, Beneteau, Bystrom, Ralhan, Trivedi); whether an 18th person exists outside this list, and their individual share count, was not separately confirmed.